| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 520.529 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 581.817 | 93 |
| GSM780709 | Untreated after 4 days (C3_1) | 515.393 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 503.64 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 585.811 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 532.165 | 92 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 599.587 | 93 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 492.481 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 533.282 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 633.791 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 527.479 | 92 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 523.661 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 451.58 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 532.165 | 92 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 571.903 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 442.47 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 526.392 | 92 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 513.974 | 92 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 449.079 | 91 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 489.802 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 548.365 | 92 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 448.936 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 511.847 | 92 |